Lv4
520 积分 2023-01-13 加入
II. HIF-PH Inhibitors for the Treatment of Anemia in CKD
2小时前
已关闭
Cardiac Myosin Inhibitors and Incident Atrial Fibrillation in Hypertrophic Cardiomyopathy: Systematic Review and Meta‐Analysis
1个月前
已完结
Long-term safety and efficacy of aficamten in the evolving era of myosin inhibition for obstructive hypertrophic cardiomyopathy
1个月前
已完结
Comprehensive evaluation of hypertrophic cardiomyopathy: European Journal of Heart Failure expert consensus document
1个月前
已完结
Efficacy and Safety of Mavacamten and Aficamten in Obstructive and Non-obstructive Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis
1个月前
已关闭
In vitro and in vivo preclinical pharmacokinetic characterization of aficamten, a small molecule cardiac myosin inhibitor
1个月前
已完结
Glycoconjugation of Quinoline as an Effective Strategy for Selective Inhibition of mTORC1
2个月前
已完结
Aficamten—A Second in Class Cardiac Myosin Inhibitor for Hypertrophic Cardiomyopathy
2个月前
已完结
Aficamten in the treatment of obstructive hypertrophic cardiomyopathy
2个月前
已完结
A Characterization of the Nonclinical Pharmacology and Toxicology of Aficamten, a Reversible Allosteric Inhibitor of Cardiac Myosin
2个月前
已完结
皖公网安备34019202002308
